drugset / Trial / NCT01774435
Study in Stabilized Schizophrenic Patients to Evaluate the Pharmacokinetics of Risperidone and 9-Hydroxy (OH)-Risperidone When Risperidone is Administered From a Polyurethane Implant
NaSingle-groupOpen-labelTreatment
Summary
This is an study evaluating the safety, tolerability, and PK of EN3342 in implantation durations of 6 months.
Timeline
- Start
- 2012-10
- Primary completion
- 2013-10
- Completion
- 2013-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | — | Subcutaneous |